share_log

A股异动丨恒瑞医药午后一度涨超5.5%,布比卡因脂质体注射液已获FDA批准

Gelonghui Finance ·  Jul 3 01:55
格隆汇7月3日|恒瑞医药(600276.SH)午后一度涨超5.5%,现涨3.66%报38.84元,总市值2478亿元。恒瑞医药昨日公告,近日,公司收到美国食品药品监督管理局通知,公司向美国FDA申报的布比卡因脂质体注射液ANDA已获得批准,是首家在美国获得该品种仿制药批准的厂家。布比卡因是临床上广泛用于局部麻醉和术后镇痛的酰胺类局部麻醉剂。
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment